NYSE:USNA USANA Health Sciences (USNA) Stock Price, News & Analysis $27.07 -0.03 (-0.11%) Closing price 04/25/2025 03:59 PM EasternExtended Trading$27.18 +0.11 (+0.42%) As of 04/25/2025 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock About USANA Health Sciences Stock (NYSE:USNA) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get USANA Health Sciences alerts:Sign Up Key Stats Today's Range$26.46▼$27.2050-Day Range$23.51▼$33.1852-Week Range$23.10▼$49.78Volume295,874 shsAverage Volume122,357 shsMarket Capitalization$510.54 millionP/E Ratio9.57Dividend YieldN/APrice Target$36.00Consensus RatingHold Company OverviewUSANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products through retail stores and online. The company has a research collaboration agreement with Beijing University of Chinese Medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.Read More… USANA Health Sciences Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks91st Percentile Overall ScoreUSNA MarketRank™: USANA Health Sciences scored higher than 91% of companies evaluated by MarketBeat, and ranked 71st out of 916 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.0 / 5Analyst RatingHold Consensus RatingUSANA Health Sciences has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 2 hold ratings, and no sell ratings.Amount of Analyst CoverageUSANA Health Sciences has only been the subject of 2 research reports in the past 90 days.Read more about USANA Health Sciences' stock forecast and price target. Earnings and Valuation4.4 / 5Proj. Earnings Growth17.96% Earnings GrowthEarnings for USANA Health Sciences are expected to grow by 17.96% in the coming year, from $2.45 to $2.89 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of USANA Health Sciences is 9.57, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 21.70.Price to Earnings Ratio vs. SectorThe P/E ratio of USANA Health Sciences is 9.57, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 22.43.Price to Earnings Growth RatioUSANA Health Sciences has a PEG Ratio of 0.93. PEG Ratios below 1 indicate that a company could be undervalued.Price to Book Value per Share RatioUSANA Health Sciences has a P/B Ratio of 1.04. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted7.30% of the float of USANA Health Sciences has been sold short.Short Interest Ratio / Days to CoverUSANA Health Sciences has a short interest ratio ("days to cover") of 3.7, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in USANA Health Sciences has recently increased by 7.17%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldUSANA Health Sciences does not currently pay a dividend.Dividend GrowthUSANA Health Sciences does not have a long track record of dividend growth. Sustainability and ESG3.2 / 5Environmental Score-2.09 Percentage of Shares Shorted7.30% of the float of USANA Health Sciences has been sold short.Short Interest Ratio / Days to CoverUSANA Health Sciences has a short interest ratio ("days to cover") of 3.7, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in USANA Health Sciences has recently increased by 7.17%, indicating that investor sentiment is decreasing significantly. News and Social Media2.0 / 5News Sentiment0.52 News SentimentUSANA Health Sciences has a news sentiment score of 0.52. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.86 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 26 news articles for USANA Health Sciences this week, compared to 4 articles on an average week.MarketBeat FollowsOnly 1 people have added USANA Health Sciences to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Company Ownership1.7 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, USANA Health Sciences insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $500,285.00 in company stock.Percentage Held by InsidersOnly 0.63% of the stock of USANA Health Sciences is held by insiders.Percentage Held by Institutions54.25% of the stock of USANA Health Sciences is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about USANA Health Sciences' insider trading history. Receive USNA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for USANA Health Sciences and its competitors with MarketBeat's FREE daily newsletter. Email Address USNA Stock News HeadlinesSidoti Csr Brokers Increase Earnings Estimates for USNAApril 27 at 2:19 AM | americanbankingnews.comSidoti Csr Cuts Earnings Estimates for USANA Health SciencesApril 25 at 3:11 AM | americanbankingnews.comURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “gold analysts” have it all wrong… They tell you to invest in gold ETFs - because the popular mining ETFs will someday catch fire and close the price gap with spot gold. April 27, 2025 | Golden Portfolio (Ad)USANA Health Sciences (NYSE:USNA) Trading Up 16% on Earnings BeatApril 25 at 1:13 AM | americanbankingnews.comUsana Health Sciences Inc (USNA) Q1 2025 Earnings Call Highlights: Strong Sales Growth and ...April 24 at 11:21 AM | finance.yahoo.comUSANA Health Sciences Sees Sales Growth Amid Earnings DeclineApril 24 at 12:21 AM | tipranks.comQ1 2025 USANA Health Sciences Inc Earnings Call TranscriptApril 24 at 12:21 AM | gurufocus.comUSANA Philippines Named Among Most Trusted Brands by Reader's DigestApril 23, 2025 | finance.yahoo.comSee More Headlines USNA Stock Analysis - Frequently Asked Questions How have USNA shares performed this year? USANA Health Sciences' stock was trading at $35.89 on January 1st, 2025. Since then, USNA stock has decreased by 24.6% and is now trading at $27.07. View the best growth stocks for 2025 here. How were USANA Health Sciences' earnings last quarter? USANA Health Sciences, Inc. (NYSE:USNA) announced its earnings results on Tuesday, April, 22nd. The company reported $0.73 EPS for the quarter, beating analysts' consensus estimates of $0.70 by $0.03. The company earned $249.54 million during the quarter, compared to analyst estimates of $243.08 million. USANA Health Sciences had a trailing twelve-month return on equity of 10.64% and a net margin of 6.30%. Read the conference call transcript. Who are USANA Health Sciences' major shareholders? Top institutional shareholders of USANA Health Sciences include Assenagon Asset Management S.A. (0.55%), Rhumbline Advisers (0.19%), Robeco Institutional Asset Management B.V. (0.10%) and Exchange Traded Concepts LLC (0.05%). Insiders that own company stock include Myron W Wentz, Jim Brown, David Mulham Mulham, Kevin Guest, John Turman Fleming, Peggie Pelosi, Frederic J Winssinger, Xia Ding, Daniel A Macuga, Paul A Jones, Robert A Sinnott, Gilbert A Fuller, Joshua Foukas, Walter Noot, G Doug Iiekking and Brent Neidig. View institutional ownership trends. How do I buy shares of USANA Health Sciences? Shares of USNA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of USANA Health Sciences own? Based on aggregate information from My MarketBeat watchlists, some other companies that USANA Health Sciences investors own include NVIDIA (NVDA), Meta Platforms (META), Tesla (TSLA), Advanced Micro Devices (AMD), JPMorgan Chase & Co. (JPM), Home Depot (HD) and Netflix (NFLX). Company Calendar Last Earnings4/22/2025Today4/27/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Medicinals & botanicals Sub-IndustryPersonal Products Current SymbolNYSE:USNA CIK896264 Webwww.usana.com Phone(801) 954-7100Fax801-954-7300Employees1,900Year FoundedN/APrice Target and Rating Average Stock Price Target$36.00 High Stock Price Target$36.00 Low Stock Price Target$36.00 Potential Upside/Downside+33.0%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)$1.82 Trailing P/E Ratio9.57 Forward P/E Ratio11.05 P/E Growth0.93Net Income$63.79 million Net Margins6.30% Pretax Margin10.73% Return on Equity10.64% Return on Assets8.48% Debt Debt-to-Equity RatioN/A Current Ratio3.93 Quick Ratio3.37 Sales & Book Value Annual Sales$876.24 million Price / Sales0.58 Cash Flow$3.71 per share Price / Cash Flow7.29 Book Value$25.99 per share Price / Book1.04Miscellaneous Outstanding Shares18,860,000Free Float18,997,000Market Cap$510.54 million OptionableOptionable Beta1.00 Social Links Elon Musk's Next MoveExplore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.Get This Free Report This page (NYSE:USNA) was last updated on 4/27/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | Sponsored"I'm risking my reputation on this"I've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredTrump purposefully forcing markets to crash…Whether you agree with the plan or not doesn’t matter. It’s happening. The only question is – are you re...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding USANA Health Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share USANA Health Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.